摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-bis-[2-(4-methoxy-benzylsulfanyl)-ethyl]-ethylenediamine | 189950-27-4

中文名称
——
中文别名
——
英文名称
N,N'-bis-[2-(4-methoxy-benzylsulfanyl)-ethyl]-ethylenediamine
英文别名
N,N'-bis[2-[(4-methoxyphenyl)methylsulfanyl]ethyl]ethane-1,2-diamine
N,N'-bis-[2-(4-methoxy-benzylsulfanyl)-ethyl]-ethylenediamine化学式
CAS
189950-27-4
化学式
C22H32N2O2S2
mdl
——
分子量
420.64
InChiKey
FGRLWFPXDDEELJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    581.0±50.0 °C(Predicted)
  • 密度:
    1.119±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    28
  • 可旋转键数:
    15
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    93.1
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Radiopharmaceuticals for diagnosing alzheimer's disease
    申请人:Schering AG
    公开号:US20020131932A1
    公开(公告)日:2002-09-19
    This invention is directed to the use of radiopharmaceuticals in diagnosing Alzheimer's disease. In particular the radiopharmaceuticals of the invention are able to pass through the blood-brain barrier and bind to the CCR1 receptor present in brain tissue of patients having Alzheimer's disease.
    这项发明涉及在诊断阿尔茨海默病中使用放射性药物。具体来说,该发明的放射性药物能够穿过血脑屏障,并结合到患有阿尔茨海默病的患者脑组织中存在的CCR1受体上。
  • Synthesis of a technetium-99m labeled tricyclic ganciclovir analog for non-invasive reporter gene expression imaging
    作者:Yi Zhang、Jing Lin、Dongfeng Pan
    DOI:10.1016/j.bmcl.2006.10.077
    日期:2007.2
    A potential radiopharmaceutical and HSV1-TK substrate, 3-((1,3-dihydroxypropan-2-yloxy)-methyl)-6-(4-(3-((2-mercaptoethyl)(2-(2-mercaptoethyl-amino)-ethyl)amino)propoxy)phenyl)-3H-imidazopurin-9(5H)-one-oxo-technetium(V), was synthesized via a converging approach and its chemical structure was comparatively characterized with a non-radioactive analog. The final radiochemical purity and yield were 97 and 73%, respectively. (c) 2006 Elsevier Ltd. All rights reserved.
  • Novel Benzofurans with <sup>99m</sup>Tc Complexes as Probes for Imaging Cerebral β-Amyloid Plaques
    作者:Masahiro Ono、Yasufumi Fuchi、Takeshi Fuchigami、Nobuya Kobashi、Hiroyuki Kimura、Mamoru Haratake、Hideo Saji、Morio Nakayama
    DOI:10.1021/ml100140d
    日期:2010.11.11
    Two novel benzofuran derivatives coupled with Tc-99m complexes were tested as probes for imaging cerebral beta-amyloid plaques using single photon emission tomography. Although both derivatives bound to A beta(1-42) aggregates, Tc-99m-BAT-BF showed higher affinity than. Tc-99m-MAMA-BF. In sections of brain tissue from an animal model of AD, Tc-99m-BAT-BF clearly labeled beta-amyloid plaques in biodistribution experiments using normal mice Tc-99m-BAT-BF displayed high uptake soon after its injection and washed out from the brain rapidly, a highly desirable feature for an imaging agent. Tc-99m-BAT-BF may be a potential probe for imaging beta-amyloid plaques in Alzheimer's brains.
  • Oya, S.; Kung, M.-P.; Mu, M., Journal of labelled compounds and radiopharmaceuticals, 1997, vol. 40, p. 431 - 433
    作者:Oya, S.、Kung, M.-P.、Mu, M.、Kung, H. F.
    DOI:——
    日期:——
  • US6676926B2
    申请人:——
    公开号:US6676926B2
    公开(公告)日:2004-01-13
查看更多